Author:
Lascano Jorge,Oshins Regina,Eagan Christina,Wadood Zerka,Qiang Xiao,Flagg Tammy,Scindia Yogesh,Mehrad Borna,Brantly Mark,Khodayari Nazli
Abstract
AbstractBackgroundSevere acute respiratory syndrome caused by a novel coronavirus 2 (SARS-CoV-2) has infected more than 18 million people worldwide. The activation of endothelial cells is a hallmark of signs of SARS-CoV-2 infection that includes altered integrity of vessel barrier and endothelial inflammation.ObjectivesPulmonary endothelial activation is suggested to be related to the profound neutrophil elastase (NE) activity, which is necessary for sterilization of phagocytosed bacterial pathogens. However, unopposed activity of NE increases alveolocapillary permeability and extracellular matrix degradation. The uncontrolled protease activity of NE during the inflammatory phase of lung diseases might be due to the resistance of exosome associated NE to inhibition by alpha-1 antitrypsin.Method31 subjects with a diagnosis of SARS-CoV2 infection were recruited in the disease group and samples from 30 voluntaries matched for age and sex were also collected for control.ResultsWe measured the plasma levels of exosome-associated NE in SARS-CoV-2 patients which, was positively correlated with the endothelial damage in those patients. Notably, we also found strong correlation with plasma levels of alpha-1 antitrypsin and exosome-associated NE in SARS-CoV-2 patients. Using macrovascular endothelial cells, we also observed that purified NE activity is inhibited by purified alpha-1 antitrypsin while, NE associated with exosomes are resistant to inhibition and show less sensitivity to alpha-1 antitrypsin inhibitory activity, in vitro.ConclusionsOur results point out the role of exosome-associated NE in exacerbation of endothelial injury in SARS-CoV-2 infection. We have demonstrated that exosome-associated NE could be served as a new potential therapeutic target of severe systemic manifestations of SARS-CoV-2 infection.
Publisher
Cold Spring Harbor Laboratory
Reference60 articles.
1. Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years
2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
3. Barnes BJ , Adrover JM , Baxter-Stoltzfus A , Borczuk A , Cools-Lartigue J , Crawford JM , Dassler-Plenker J , Guerci P , Huynh C , Knight JS , Loda M , Looney MR , McAllister F , Rayes R , Renaud S , Rousseau S , Salvatore S , Schwartz RE , Spicer JD , Yost CC , Weber A , Zuo Y , Egeblad M. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med 2020; 217.
4. What drives neutrophils to the alveoli in ARDS?
5. Yang SC , Tsai YF , Pan YL , Hwang TL . Understanding the role of neutrophils in acute respiratory distress syndrome. Biomed J 2020.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献